Articles tagged "Liver transplantation"

2019 American Transplant Congress
Personality Traits of Liver Transplant Candidates – Unappreciated Challenges
D. Ladner¹, J. Lai², A. N. Hall¹, E. D. Bastarache¹, A. Daud¹, T. Bogg³, A. Lebsack¹, T. Kalume¹, D. Mroczek¹
¹Northwestern University, Chicago, IL, ²UCSF, San Francisco, CA, ³Wayne State University, Chicago, IL
*Purpose: Liver transplant candidates are chronically ill, requiring complex medical care prior to and after transplant to optimize outcomes. Conscientiousness is one of the Big…
2019 American Transplant Congress
Redefining Cirrhotic Cardiomyopathy; A Shifting Paradigm
M. J. Izzy¹, M. Angirekula², M. Leise², A. Allen², K. Watt²
¹Gastroenterology and Hepatology, Vanderbilt University Medical Center, Nashville, TN, ²Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Diastolic dysfunction (DD) is the hallmark of cirrhotic cardiomyopathy (CCM) for which criteria were established in 2005. Based on those criteria, the prevalence of…
2019 American Transplant Congress
Totally Robotic Donor Hepatectomy: Feasibility And Early Outcomes
Y. Cheah, C. J. Simon, W. D. Lewis, R. L. Jenkins, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: Robotic surgery is emerging as a surgical technique to enable resection of the liver using minimally invasive techniques; however, very few living donor liver…
2019 American Transplant Congress
Share 21 Rather Than Share 15: Balancing Transplant Opportunity without Compromising Waitlist Outcomes
S. Nagai¹, L. C. Chau¹, M. Abouljoud¹, K. Collins¹, S. Jafri², M. Safwan¹, D. Moonka²
¹Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI, ²Gastroenterology, Henry Ford Hospital, Detroit, MI
*Purpose: We recently reported that, with the introduction of Meld-Na liver allocation, the score at which patients clearly benefit from liver transplant as opposed to…
2019 American Transplant Congress
500 Pediatric Liver Transplants At A Freestanding Pediatric Hospital – Where It Is Done Best
A. Rana, M. Kueht, N. Galvan, R. Cotton, C. O'Mahony, J. Goss
Baylor College of Medicine, Houston, TX
*Purpose: Our institution, a freestanding pediatric hospital (FPH) has a large pediatric liver transplant (LT) experience. Our aim was to analyze our experience with other…
2019 American Transplant Congress
Mortality around the One-Year Survival Metric after Liver Transplantation in the United States
C. Blebea¹, P. Chatterjee², A. Nathan¹, J. Diamond¹, H. J. Goldberg², A. Courtwright¹
¹Hospital of the University of Pennsylvania, Philadelphia, PA, ²Brigham and Women’s Hospital, Boston, MA
*Purpose: Liver transplant programs in the United States are evaluated on one-year survival, among other factors. This may create an unintended incentive to continue life-sustaining…
2019 American Transplant Congress
Karnofsky Performance Score as a Predictor of Acute Cellular Rejection Post Liver Transplantation
N. Kapila¹, K. Al Khalloufi², F. Salomon³, K. Kapila⁴, A. Gupta³, X. B. Zervos²
¹Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL, ²Transplant, Cleveland Clinic Florida, Weston, FL, ³Internal Medicine, Cleveland Clinic Florida, Weston, FL, ⁴Internal Medicine, University of Miami/JFK Medical Center, Atlantis, FL
*Purpose: The incidence of acute cellular rejection (ACR) following liver transplantation (LT) ranges from 20-40%. Development of ACR is associated with increased risk of graft…
2019 American Transplant Congress
Comprehensive and Combined Transcriptomic and Proteomic Analysis Reveals Key Factors Underlying Ischemia-Reperfusion Injury in Human Liver Transplantation
S. Huang, X. He, C. Sun, Z. Guo, W. Ju, Z. Zhu, Q. Zhao, G. Chen
Organ Transplant Center, the First Affiliated Hospital of SYSU, Guangzhou, China
*Purpose: Ischemia-reperfusion injury (IRI) is a major challenge in liver resection and liver transplantation surgery. Hepatic IRI can seriously impair liver function and even cause…
2019 American Transplant Congress
Clinical Features and Prognosis of Diffuse Intrahepatic Biliary Stricture in Adult ABO-Incompatible Living Donor Liver Transplantation
J. Kwon, G. Song, S. Hwang, K. Kim, C. Ahn, D. Moon, T. Ha, D. Jung, G. Park, Y. Yoon, H. Cho, I. Jeong, J. Choi, S. Yoo, S. Lee
Division of Liver Transplantation and Hepatobiliary Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
*Purpose: Despite the advancement in desensitization protocol, diffuse intrahepatic biliary stricture (DIHBS), an attenuated form of antibody mediated rejection (AMR), remains an unresolved problem. As…
2019 American Transplant Congress
Preliminary Mechanistic Studies of Regulatory Dendritic Cell (DCreg) Cell Infusion in Living Donor Liver Transplant Recipients
A. Thomson, C. Macedo, A. Zahorchak, H. Dai, A. Humar, F. G. Lakkis, M. Styn, D. Metes
Starzl Transplantation Institute, Pittsburgh, PA
*Purpose: This is a first-in-human phase I/II safety and preliminary efficacy trial of donor-derived regulatory dendritic cells (DCreg) in living donor liver transplantation (LTx) in…